Detalles de la búsqueda
1.
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study.
Neuroendocrinology;
112(1): 88-100, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508849
2.
An unusual complication of tumor surgery: chylous leakage.
Surg Today;
52(2): 330-336, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34223990
3.
Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
Diabetologia;
64(1): 142-151, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33043402
4.
Intestinal occlusion by gynecological cancers treated by percutaneous endoscopic gastrostomy and lanreotide: an Aviano National Cancer Institute experience.
Support Care Cancer;
29(2): 547-549, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914327
5.
Somatostatin administration following pancreatoduodenectomy: a case-matched comparison according to surgical technique, body mass index, American Society of Anesthesiologists' score and Fistula Risk Score.
Surg Today;
51(6): 1044-1053, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270148
6.
Self-Administration of Long-Acting Somatostatin Analogues in NET Patients-Does It Affect the Clinical Outcome?
Medicina (Kaunas);
57(12)2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34946232
7.
Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors.
Cancer;
126(16): 3689-3697, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32525561
8.
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
Gastroenterology;
157(2): 481-491.e7, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022403
9.
Pasireotide administration after pancreaticoduodenectomy may decrease clinically relevant postoperative pancreatic fistula in high-risk patients with small pancreatic ducts, soft pancreatic parenchyma and cystic or neuroendocrine neoplasia.
Pancreatology;
20(4): 757-761, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307251
10.
Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study).
Pancreatology;
20(6): 1183-1188, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798144
11.
Risk-stratified analysis of pasireotide for patients undergoing pancreatectomy.
J Surg Oncol;
122(2): 195-203, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474957
12.
Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies.
BMC Endocr Disord;
20(1): 126, 2020 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811475
13.
Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.
BMC Endocr Disord;
20(1): 117, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32736547
14.
Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN).
BMC Endocr Disord;
20(1): 57, 2020 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366244
15.
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling.
J Pharmacokinet Pharmacodyn;
47(3): 229-239, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32248329
16.
Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review.
BMC Surg;
20(1): 304, 2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256692
17.
A plausible way for excretion of metal nanoparticles via active targeting.
Drug Dev Ind Pharm;
46(5): 744-750, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32250174
18.
E-cadherin expression is associated with somatostatin analogue response in acromegaly.
J Cell Mol Med;
23(5): 3088-3096, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843342
19.
Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study.
Invest New Drugs;
37(3): 573-578, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267338
20.
Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
Eur Radiol;
29(6): 3062-3068, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30542749